Japan· JP-2699711Q1116
アダパレン
A adapalene product containing アダパレン, registered in Japan by 東光薬品工業, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Adapalene is registered in 16 of 19 countries.
Countries holding a registration under ATC D10AD03 (adapalene), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Adapalene · ATC D10AD03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アダパレン
- Manufacturer
- 東光薬品工業
- Country
- Japan (JP)
- ATC code
- D10AD03
- ATC class
- Adapalene
- Defined daily dose
- 1 mg, T
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for adapalene.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Adapalene · interactions on record
80 records
- 1 severe
- 8 moderate
- 71 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- IsotretinoinD10AD04moderate
- Benzoyl peroxideD10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D10AD03
Adapalene, as other registers publish it.
- United StatesACNE TREATMENTJiangxi Zhongteng Pharmaceutical Co., Ltd
- PolandAcnelecBausch Health Ireland Ltd.
- PolandAcnelecBausch Health Ireland Ltd.
- DenmarkAdapalen "2care4"2care4 ApS
- DenmarkAdapalen "Cabo"Cabo Medicine ApS
- DenmarkAdapalen "Nordic Prime"Nordic Prime ApS
- United StatesadapaleneActavis Pharma, Inc.
- United StatesAdapaleneWalgreens
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbed532d-12ba-469c-9b54-b19beb0b603e GET /v1/drugs/dbed532d-12ba-469c-9b54-b19beb0b603e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．１％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2699711Q1116",
"category": "外用薬",
"price_yen": 17.9,
"generic_name": "アダパレン",
"product_name_jp": null,
"therapeutic_class": "2699",
"transitional_expiry": null
}See everything about adapalene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.